Bitrobius Genetics Ltd
Company Profile
Bitrobius Genetics Ltd
13040147•Private Limited With Share Capital
Get Full Access
24/11/2020
5 years
3
6
72110
very low risk
Company Overview
Registration, classification & business activity
Bitrobius Genetics Ltd (13040147) is a private limited with share capital incorporated on 24/11/2020 (5 years old) and registered in macclesfield, SK104TG. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Bitrobius genetics is developing the gentrafix platform to solve the major problem with gene therapy: the inability of therapeutic genes to reach most of the cells in an affected organ or tissue. it promises to revolutionise the treatment of genetic diseases and cancers.
Financial Overview
£1.01M
£12.7K
£997.6K
£737.5K
Key Metrics
6
Employees
3
Directors
8
Shareholders
1
Patents
Board of Directors
Filed Documents
Innovate Grants
This company received a grant of £698319.0 for Development Of Novel Therapies For Genetic Diseases Using The Gentrafix Platform. The project started on 01/09/2023 and ended on 31/05/2026.
This company received a grant of £150000.0 for Intercellular Transfer Of Therapeutic Dna For Gene And Cancer Therapies. The project started on 01/08/2021 and ended on 31/01/2023.
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
good
Performance Rating